05/02/2026
Medical Ma*****na Caregivers of Maine Trade Association
Federal Rescheduling Update – Member Brief
The Medical Ma*****na Caregivers of Maine Trade Association would like to provide members with a brief update regarding recent federal action by the U.S. Department of Justice (DOJ) and Drug Enforcement Administration (DEA) concerning the rescheduling of certain ma*****na-related substances.
The federal government has initiated a shift to place certain ma*****na products into Schedule III of the Controlled Substances Act, recognizing potential medical use and a lower level of risk compared to Schedule I substances. This represents a significant policy change at the federal level and may signal the beginning of a longer-term transition toward a more structured federal framework for medical cannabis.
Current Understanding
At this time, it is important to emphasize:
There is currently no clear operational guidance from the DEA regarding how existing state-licensed medical cannabis providers, including Maine caregivers, will be integrated into or affected by this new framework.
The federal system appears to be developing as a separate and more highly regulated pathway, distinct from existing state programs.
Maine’s medical cannabis program remains in place and unchanged at this time, and caregivers may continue operating under current state law.
While a federal registration pathway is being introduced, many critical details—including supply chain requirements, compliance expectations, and practical implementation—remain unclear.
Regarding DEA Registration
At this stage, the Association’s position is as follows:
As presented by the federal government, aspects of this new framework may suggest that federal registration could become necessary in certain contexts in the future; however, it is not clearly defined at this time whether this will be mandatory for existing state-licensed caregivers.
The DEA has provided an early registration window of approximately 60 days, currently understood to run through June 22, for those considering initial application.
It remains unclear what advantages, obligations, or long-term implications are associated with applying within this early window versus applying at a later time.
We do not yet have clarity on how federal requirements may be implemented alongside Maine’s current medical cannabis program.
It is also unclear how the State of Maine will respond or adapt to these federal changes, or whether additional state-level requirements may be introduced.
Given these uncertainties:
The Association is not encouraging or discouraging members to apply for a DEA registration at this time.
The decision to apply should be made individually, based on each caregiver’s business model, risk tolerance, and consultation with qualified professionals.
Members are encouraged to:
Stay informed
Seek legal and financial guidance
Avoid making rushed decisions based on incomplete or evolving information
What the Association Is Doing.
The Association is actively consulting with legal experts, regulatory professionals, and industry leaders
Monitoring developments at both the federal and state levels
Working to ensure that Maine caregivers remain informed, represented, and prepared
Upcoming Networking Meeting -
At this month’s networking meeting, we are pleased to welcome Guest Speaker, Attorney Jill Cohen.
Attorney Cohen will provide her legal perspective on:
Current federal developments
Potential implications for Maine caregivers
Considerations surrounding DEA registration
What to watch for as this situation evolves
This is an evolving and complex situation. While federal recognition of medical cannabis represents an important shift, the practical impact on Maine caregivers is still uncertain.
At this time, caregivers should continue operating in compliance with Maine law while remaining attentive to new developments. The Association will continue to provide updates as clearer guidance becomes available.
